New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Propanc’s PRP is a proprietary intravenous formulation designed to selectively attack cancer stem cells and circulating tumor cells while sparing healthy tissue — offering potential as a long-term ...
This case addresses two primary issues (i) whether the district court erred in construing the claim term “composition” in FMC’s pesticide patents ...
Adial Pharmaceuticals, Inc. announced an update to its provisional patent application for AD04, a serotonin-3 receptor antagonist aimed at treating Alcohol Use Disorder in heavy drinking patients, ...
For startups sensitive to cash burn rate, provisional patent applications often seem like the perfect solution—lower filing fees, simplified requirements, and a full year to file the "real" ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
ingest multiple data types from any source in real-time, and then overlay these disparate datasets to present a composite of context enrichments focused on delivering intuitive analysis and views of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You have a great idea for an invention, and you think it is ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. The provisional patent ...
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent ...